HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Hyperfine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.78+0.02 (+2.97%)
Close on Oct 19, 2026
- Market cap
- $77.56M
- P/E (TTM)
- –
- Dividend yield
- –
Hyperfine, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Device | $3.17M | $3.26M | $4.86M | $2.89M | $2.13M | $1.52M | $1.74M | $3.03M | $2.97M | $2.70M | $2.08M | $1.73M | 81.2% | +49.0% |
| Service | $734.00K | $646.00K | $436.00K | $546.00K | $568.00K | $615.00K | $578.00K | $610.00K | $661.00K | $591.00K | $610.00K | $602.00K | 18.8% | +29.2% |
By region
From the segment and revenue-disaggregation notes of Hyperfine's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.